Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Inhibikase Therapeutics
IKT
$377M
| $31K | ﹤0.01% |
24,422
+8,300
| +51% | +$8.59K |
|
3527
Oriental Culture Holding
OCG
$3.24M
| $31K | ﹤0.01% |
32
+1
| +3% | +$969 |
|
3528
BiomX
PHGE
$1.67M
| $31K | ﹤0.01% |
580
-181
| -24% | -$11.4K |
|
3529
TransCode Therapeutics
RNAZ
$3.57M
| $31K | ﹤0.01% |
+5
| New | +$56.2K |
|
3530
VCI Global
VCIG
$2.57M
| – | – |
0
| – | – |
|
|
GLDG
3531
GoldMining Inc
GLDG
$223M
| $30K | ﹤0.01% |
+31,249
| New | +$27K |
|
3532
Taoping
TAOP
$8.83M
| $30K | ﹤0.01% |
+681
| New | +$34.1K |
|
|
FLZH
3533
Flash Sports & Media Holdings
FLZH
$71.1M
| $30K | ﹤0.01% |
864
+368
| +74% | +$11.2K |
|
3534
Unicycive Therapeutics
UNCY
$150M
| $30K | ﹤0.01% |
+3,409
| New | +$22.3K |
|
3535
GT Biopharma
GTBP
$10.9M
| $29K | ﹤0.01% |
3,823
+1,600
| +72% | +$11.7K |
|
3536
Nauticus Robotics
KITT
$8.35M
| $29K | ﹤0.01% |
+16
| New | +$61K |
|
3537
Exicure
XCUR
$8.29M
| $29K | ﹤0.01% |
9,900
-1,700
| -15% | -$5.08K |
|
|
CLYM
3538
Climb Bio
CLYM
$827M
| $29K | ﹤0.01% |
+10,603
| New | +$27.6K |
|
3539
Fusion Fuel Green
HTOO
$17.9M
| $28K | ﹤0.01% |
723
+12
| +2% | +$372 |
|
3540
SuperCom
SPCB
$70.3M
| $28K | ﹤0.01% |
+3,600
| New | +$29.8K |
|
|
OPGN
3541
DELISTED
OpGen, Inc
OPGN
| $28K | ﹤0.01% |
+6,600
| New | +$35.2K |
|
|
SRXH
3542
SRX Global
SRXH
$35.9M
| $27K | ﹤0.01% |
50
-4
| -7% | -$1.95K |
|
3543
Candel Therapeutics
CADL
$865M
| $27K | ﹤0.01% |
+18,675
| New | +$18.1K |
|
|
CREG
3544
DELISTED
Smart Powerr
CREG
| $27K | ﹤0.01% |
171
-6
| -3% | -$720 |
|
|
FURY
3545
Fury Gold Mines
FURY
$116M
| $27K | ﹤0.01% |
53,100
-92,002
| -63% | -$35.6K |
|
3546
IN8bio
INAB
$9.83M
| $27K | ﹤0.01% |
+653
| New | +$20.9K |
|
3547
Iveda Solutions
IVDA
$6.09M
| $27K | ﹤0.01% |
+5,288
| New | +$30.3K |
|
3548
Polar Power
POLA
$7.13M
| $27K | ﹤0.01% |
+9,470
| New | +$50K |
|
3549
Alaunos Therapeutics
TCRT
$4.88M
| $27K | ﹤0.01% |
+2,547
| New | +$30.7K |
|
|
WAVE
3550
Eco Wave Power Global
WAVE
$45.2M
| $27K | ﹤0.01% |
+21,495
| New | +$43.2K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.